Empagduo Tablet 5/1000 mg
Empagliflozin 5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Myeongmun Pharmaceutical Co., Ltd.
MFDS item code 202201373 · Approved 2022.04.04
Improvement of glycemic control in adults with type 2 diabetes mellitus
This medicine is recommended for use in conjunction with dietary and exercise therapy to help adults with type 2 diabetes manage blood sugar levels. It is particularly used for patients with cardiovascular disease among those whose blood sugar management is insufficient. This medicine can help improve blood sugar control, aiding in diabetes management and reducing cardiovascular risks. When administering, please refer to the guidance of specialists and precautions for use. For these reasons, it is effectively used in the treatment of type 2 diabetes.
The recommended dose is 1 tablet twice daily. The dose should be determined based on each patient's current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended daily doses of each component: empagliflozin 25 mg and metformin 2000 mg. ⦁ For patients whose blood glucose is not adequately controlled with metformin alone or in combination with other medicines such as insulin, the recommended dose is empagliflozin 5 mg twice daily (total daily dose 10 mg) and the patient's current metformin dose. If empagliflozin 10 mg (total daily dose) is well tolerated and additional blood glucose control is needed, the dose may be increased to empagliflozin 25 mg (total daily dose). ⦁ Patients switching from combination therapy with empagliflozin (total daily dose 10 mg or 25 mg) and metformin to this medicine should receive their current doses of empagliflozin and metformin. When this medicine is used in combination with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia (see Precautions for Use, 4. Adverse Reactions and 6. Drug Interactions). This medicine should be taken with meals to reduce gastrointestinal adverse reactions associated with metformin. If you miss a dose, take it as soon as you remember. However, do not take a double dose at one time; if this happens, skip the missed dose. Special Populations Patients with Renal Impairment No dose adjustment is necessary for patients with mild renal impairment. Because this medicine contains metformin, it may be used with dose adjustment in patients with an estimated glomerular filtration rate (eGFR) of 45-59 ml/min/1.73m2 or a CrCl of 45-59 ml/min who do not have other conditions that may increase the risk of lactic acidosis. In these patients, the starting dose of metformin is 500 mg or 850 mg once daily; therefore, treatment should be initiated with the individual components, empagliflozin and metformin. The maximum daily dose of metformin hydrochloride that may be administered with this medicine is 1000 mg, given as 500 mg twice daily. Renal function should be carefully monitored every 3-6 months (see Precautions for Use, 3. Patients Requiring Caution, item 1)). If renal function declines to CrCl < 45 ml/min or eGFR < 45 ml/min/1.73m2, this medicine should be discontinued immediately (see Precautions for Use, 2. Contraindications, item 2)). Elderly Patients In patients aged 75 years or older, renal function and the risk of volume depletion should be considered.
This medicine can cause severe lactic acidosis, with reported cases of deaths resulting from it, so extreme caution is required. When using this drug in combination with other diabetes treatments, serious hypoglycemia may occur infrequently, so caution is needed. Patients with allergies to the ingredients in this medicine or moderate to severe renal impairment should not use this medicine. It should not be administered to patients with acute renal function deterioration, severe infections, cardiovascular issues, type 1 diabetes, or diabetic ketoacidosis. Before and after undergoing tests that use iodine contrast agents, administration of this medicine should be stopped and restarted only after normal renal function has been restored. In cases where surgery is planned, this medicine should be temporarily ceased 48 hours prior to surgery and resumed only after verifying normal renal function post-operation. It is safest for women who are pregnant or may become pregnant, as well as breastfeeding mothers, not to use this medicine. The use and dosage of this medicine should be adjusted according to renal function; particularly, elderly patients or those with impaired renal function should regularly monitor their kidney function. This medicine may cause side effects such as hypoglycemia, urinary infections, reproductive infections, increased urination, nausea, vomiting, diarrhea, abdominal pain, loss of appetite, constipation, liver enzyme abnormalities, hepatitis, altered taste, itching, rash, erythema, increased serum lipids, increased serum creatinine, decreased serum creatinine, decreased vitamin B12 and deficiency, fluid volume reduction, headaches, dizziness, insomnia, chest discomfort, chest pain, weakness, fever, peripheral edema, facial swelling, and increased blood pressure, thus any abnormal symptoms should be immediately discussed with healthcare personnel. Fluid loss may occur, so patients experiencing dehydration symptoms or at high risk for fluid volume loss should be cautious while taking this medicine. Patients with liver dysfunction should avoid this medicine, and if liver dysfunction symptoms appear, they should promptly inform their physician. This medicine may reduce vitamin B12 levels, so patients on long-term treatment should periodically check their vitamin B12 levels. Excessive alcohol consumption should be avoided while taking this medicine as it may increase the risk of lactic acidosis. While taking this medicine, it is necessary to maintain a regular meal and exercise routine for blood sugar control, as irregular meals or excessive exercise may increase the risk of hypoglycemia. The effects of this medicine on driving or operating machinery are not well-defined, so caution is advised. In cases of overdose, emergency measures such as hemodialysis may be required, so the dosage must be strictly adhered to. This medicine is not recommended for children and adolescents under 18 years old, as safety and efficacy have not been established in this population. This medicine should be taken strictly according to a physician's prescription and instructions, and any occurrence of unusual symptoms should be immediately discussed with healthcare personnel.
Not everyone experiences these, and they can vary from person to person.
This medicine can be sensitive to air and moisture, so it should be stored in a tightly sealed container. The storage temperature should be maintained between 1 degree and 30 degrees Celsius to safely preserve the effectiveness of the medicine.
Brownish yellow, bilaterally convex oval film-coated tablets
10 Tablets/Box [10 Tablets/PTPX1], 60 Tablets/Box [10 Tablets/PTPX6], 60 Tablets/Bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Empagliflozin 5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Myeongmun Pharmaceutical Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.